Table 2.

Phenotypic and molecular characteristics among S. aureus isolates from four animals and an employee at the Attica Zoological Park.

Species	MLST ST	MLST group	spa type	spa CC	PFGE type	PVL toxin	Antimicrobial resistance patterns	Colonized/infected (C/I)
Cretan wild goat	133	10	t053	S	XIX	N	Fusidic acid	C
Shetland pony-1	45	3	t053	S	G	N	Susceptible	C
Shetland pony-1	45	3	t094	S	XX	N	Susceptible	C
Squirrel monkey-1	15	1	t5559	S	XXI	N	Tetracycline, fusidic acid	C
Squirrel monkey-1	8	1	t053	S	XXII	P	Susceptible	I
Rabbit -1	1	1	t2049	Common	XXIV	N	Susceptible	C
Rabbit -1	410	New	t111	CC	XXIII	N	Susceptible	C
Human	80	14	t053	S	C	N	Susceptible	C

ST: Sequence types assigned by multi-locus sequence typing (MLST), MLST Groups: Classified according to sequence types by eBURST (http://saureus.mlst.net/misc/info.asp). CC: Clusters assigned according to spa types by BURP clustering with Ridom StaphType (Ridom GmbH, Wurzburg, Germany): t111 and t2049 are assigned to a common CC, PFGE: Pulsed-field gel electrophoresis types, PVL: Panton-valentine leukocidin genes detected by PCR, S: Singleton, N: negative, P: positive. Antimicrobials tested: cefoxitin, tetracycline, gentamicin, rifampicin, kanamycin, erythromycin, clindamycin, fusidic acid, sulfamethoxazole-trimethoprim, oxacillin, vancomycin, teicoplanin, daptomycin and linezolid.